Telesis Bio Inc. (TBIO) Selling and Marketing Expense USD 2020 - 2024

Historical data

Taxonomy & unit: us-gaap: USD and USD
Description: The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary: Telesis Bio Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2020 to 2024.
Telesis Bio Inc. Selling and Marketing Expense for the quarter ending March 31, 2024 was $1.68 M, a 56% decline year-over-year.
Telesis Bio Inc. Selling and Marketing Expense for the twelve months ending March 31, 2024 was $11.4 M, a 32% decline year-over-year.
Telesis Bio Inc. annual Selling and Marketing Expense for 2023 was $13.5 M, a 18% decline from 2022.
Telesis Bio Inc. annual Selling and Marketing Expense for 2022 was $16.5 M, a 50.5% increase from 2021.
Telesis Bio Inc. annual Selling and Marketing Expense for 2021 was $11 M, a 58.1% increase from 2020.

Selling and Marketing Expense, Trailing 12 Months (USD)

Selling and Marketing Expense, Quarterly Data (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$11.4 M	$1.68 M	-$2.13 M	-56%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-10
Q4 2023	$13.5 M	$3.6 M	-$462 K	-11.4%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-29
Q3 2023	$14 M	$2.74 M	-$1.45 M	-34.5%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$15.4 M	$3.36 M	-$1.33 M	-28.3%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$16.8 M	$3.81 M	+$261 K	+7.36%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-10
Q4 2022	$16.5 M	$4.07 M	+$968 K	+31.2%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-29
Q3 2022	$15.5 M	$4.19 M	+$1.23 M	+41.8%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-13
Q2 2022	$14.3 M	$4.69 M	+$2.06 M	+78.3%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-11
Q1 2022	$12.2 M	$3.55 M	+$1.27 M	+55.9%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-12
Q4 2021	$11 M	$3.1 M			Oct 1, 2021	Dec 31, 2021	10-K	2023-03-22
Q3 2021		$2.96 M	+$1.09 M	+58.8%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-09
Q2 2021		$2.63 M	+$1.03 M	+64.6%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-10
Q1 2021		$2.28 M			Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-11
Q3 2020		$1.86 M			Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020		$1.6 M			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.